Elite Pharmaceuticals, Inc. Derivative Liability
Elite Pharmaceuticals, Inc. (ELTP) had Derivative Liability of $17.25 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2026-08-13
- 2026-06-30: Derivative Liability $17.25M.
- 2026-03-31: Derivative Liability $17.34M.
- 2025-06-30: Derivative Liability $47.31M.
- 2025-03-31: Derivative Liability $25.20M.
| Period end | Derivative Liability |
|---|---|
| 2026-06-30 | $17.25M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $17.34M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $47.31M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $25.20M 10-Q · filed 2026-08-13 |